They assessed the expression of AHR both in ERα-positive or ERα-negative human breast tumors and found in ER-positive cells a correlation between AHR expression, metastasis occurrence and related markers (MMP1, MMP2), and plasminogen activator urokinase (PLAU). This evidence concerns the gene ESR1 and breast neoplasm.